Literature DB >> 19536844

Improvement in hemolysis and pulmonary arterial systolic pressure in adult patients with sickle cell disease during treatment with hydroxyurea.

Matthew Olnes, Amy Chi, Carissa Haney, Rose May, Caterina Minniti, James Taylor, Gregory J Kato.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19536844      PMCID： PMC2766189          DOI： 10.1002/ajh.21446

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  16 in total

1.  Pulmonary hypertension associated with sickle cell disease: clinical and laboratory endpoints and disease outcomes.

Authors:  Laura M De Castro; Jude C Jonassaint; Felicia L Graham; Allison Ashley-Koch; Marilyn J Telen
Journal:  Am J Hematol       Date:  2008-01       Impact factor: 10.047

2.  Lactate dehydrogenase as a biomarker of hemolysis-associated nitric oxide resistance, priapism, leg ulceration, pulmonary hypertension, and death in patients with sickle cell disease.

Authors:  Gregory J Kato; Vicki McGowan; Roberto F Machado; Jane A Little; James Taylor; Claudia R Morris; James S Nichols; Xunde Wang; Mirjana Poljakovic; Sidney M Morris; Mark T Gladwin
Journal:  Blood       Date:  2005-11-15       Impact factor: 22.113

3.  Pulmonary hypertension in patients with sickle cell disease: a longitudinal study.

Authors:  Kenneth I Ataga; Charity G Moore; Susan Jones; Oludamilola Olajide; Dell Strayhorn; Alan Hinderliter; Eugene P Orringer
Journal:  Br J Haematol       Date:  2006-07       Impact factor: 6.998

4.  Effect of hydroxyurea on mortality and morbidity in adult sickle cell anemia: risks and benefits up to 9 years of treatment.

Authors:  Martin H Steinberg; Franca Barton; Oswaldo Castro; Charles H Pegelow; Samir K Ballas; Abdullah Kutlar; Eugene Orringer; Rita Bellevue; Nancy Olivieri; James Eckman; Mala Varma; Gloria Ramirez; Brian Adler; Wally Smith; Timothy Carlos; Kenneth Ataga; Laura DeCastro; Carolyn Bigelow; Yogen Saunthararajah; Margaret Telfer; Elliott Vichinsky; Susan Claster; Susan Shurin; Kenneth Bridges; Myron Waclawiw; Duane Bonds; Michael Terrin
Journal:  JAMA       Date:  2003-04-02       Impact factor: 56.272

5.  Decreased plasma endothelin-1 levels in children with sickle cell disease treated with hydroxyurea.

Authors:  Claudine Lapouméroulie; Malika Benkerrou; Marie Hélène Odièvre; Rolande Ducrocq; Manuel Brun; Jacques Elion
Journal:  Haematologica       Date:  2005-03       Impact factor: 9.941

6.  Hydroxyurea nitrosylates and activates soluble guanylyl cyclase in human erythroid cells.

Authors:  Vladan P Cokic; Silvana A Andric; Stanko S Stojilkovic; Constance T Noguchi; Alan N Schechter
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

7.  Longitudinal follow up of elevated pulmonary artery pressures in children with sickle cell disease.

Authors:  Farzana D Pashankar; Judith Carbonella; Alia Bazzy-Asaad; Alan Friedman
Journal:  Br J Haematol       Date:  2008-12-01       Impact factor: 6.998

8.  Effect of hydroxyurea on the frequency of painful crises in sickle cell anemia. Investigators of the Multicenter Study of Hydroxyurea in Sickle Cell Anemia.

Authors:  S Charache; M L Terrin; R D Moore; G J Dover; F B Barton; S V Eckert; R P McMahon; D R Bonds
Journal:  N Engl J Med       Date:  1995-05-18       Impact factor: 91.245

9.  Hydroxyurea induces the eNOS-cGMP pathway in endothelial cells.

Authors:  Vladan P Cokic; Bojana B Beleslin-Cokic; Melanija Tomic; Stanko S Stojilkovic; Constance T Noguchi; Alan N Schechter
Journal:  Blood       Date:  2006-03-09       Impact factor: 22.113

10.  Pulmonary hypertension as a risk factor for death in patients with sickle cell disease.

Authors:  Mark T Gladwin; Vandana Sachdev; Maria L Jison; Yukitaka Shizukuda; Jonathan F Plehn; Karin Minter; Bernice Brown; Wynona A Coles; James S Nichols; Inez Ernst; Lori A Hunter; William C Blackwelder; Alan N Schechter; Griffin P Rodgers; Oswaldo Castro; Frederick P Ognibene
Journal:  N Engl J Med       Date:  2004-02-26       Impact factor: 91.245
View more
  17 in total

1.  The LSD1 inhibitor RN-1 induces fetal hemoglobin synthesis and reduces disease pathology in sickle cell mice.

Authors:  Shuaiying Cui; Kim-Chew Lim; Lihong Shi; Mary Lee; Natee Jearawiriyapaisarn; Greggory Myers; Andrew Campbell; David Harro; Shigeki Iwase; Raymond C Trievel; Angela Rivers; Joseph DeSimone; Donald Lavelle; Yogen Saunthararajah; James Douglas Engel
Journal:  Blood       Date:  2015-06-01       Impact factor: 22.113

2.  Hemodynamic predictors of mortality in adults with sickle cell disease.

Authors:  Alem Mehari; Shoaib Alam; Xin Tian; Michael J Cuttica; Christopher F Barnett; George Miles; Dihua Xu; Catherine Seamon; Patricia Adams-Graves; Oswaldo L Castro; Caterina P Minniti; Vandana Sachdev; James G Taylor; Gregory J Kato; Roberto F Machado
Journal:  Am J Respir Crit Care Med       Date:  2013-04-15       Impact factor: 21.405

3.  An official American Thoracic Society clinical practice guideline: diagnosis, risk stratification, and management of pulmonary hypertension of sickle cell disease.

Authors:  Elizabeth S Klings; Roberto F Machado; Robyn J Barst; Claudia R Morris; Kamal K Mubarak; Victor R Gordeuk; Gregory J Kato; Kenneth I Ataga; J Simon Gibbs; Oswaldo Castro; Erika B Rosenzweig; Namita Sood; Lewis Hsu; Kevin C Wilson; Marilyn J Telen; Laura M Decastro; Lakshmanan Krishnamurti; Martin H Steinberg; David B Badesch; Mark T Gladwin
Journal:  Am J Respir Crit Care Med       Date:  2014-03-15       Impact factor: 21.405

4.  Anti-haemolytic effect of senicapoc and decrease in NT-proBNP in adults with sickle cell anaemia.

Authors:  Caterina P Minniti; Jonathan Wilson; Laurel Mendelsohn; Greg C Rigdon; Jonathan W Stocker; Alan T Remaley; Gregory J Kato
Journal:  Br J Haematol       Date:  2011-06-08       Impact factor: 6.998

5.  Biochemical surrogate markers of hemolysis do not correlate with directly measured erythrocyte survival in sickle cell anemia.

Authors:  Charles T Quinn; Eric P Smith; Shahriar Arbabi; Paramjit K Khera; Christopher J Lindsell; Omar Niss; Clinton H Joiner; Robert S Franco; Robert M Cohen
Journal:  Am J Hematol       Date:  2016-11-08       Impact factor: 10.047

6.  Longitudinal study of echocardiography-derived tricuspid regurgitant jet velocity in sickle cell disease.

Authors:  Payal C Desai; Ryan C May; Susan K Jones; Dell Strayhorn; Melissa Caughey; Alan Hinderliter; Kenneth I Ataga
Journal:  Br J Haematol       Date:  2013-07-06       Impact factor: 6.998

7.  Examining the characteristics and beliefs of hydroxyurea users and nonusers among adults with sickle cell disease.

Authors:  Carlton Haywood; Mary Catherine Beach; Shawn Bediako; C Patrick Carroll; Lakshmi Lattimer; Dasheema Jarrett; Sophie Lanzkron
Journal:  Am J Hematol       Date:  2011-01       Impact factor: 10.047

8.  Endothelin receptor antagonists for pulmonary hypertension in adult patients with sickle cell disease.

Authors:  Caterina P Minniti; Roberto F Machado; Wynona A Coles; Vandana Sachdev; Mark T Gladwin; Gregory J Kato
Journal:  Br J Haematol       Date:  2009-09-22       Impact factor: 6.998

9.  Vasculopathy in sickle cell disease: Biology, pathophysiology, genetics, translational medicine, and new research directions.

Authors:  Gregory J Kato; Robert P Hebbel; Martin H Steinberg; Mark T Gladwin
Journal:  Am J Hematol       Date:  2009-09       Impact factor: 10.047

10.  Vascular complications of sickle cell disease.

Authors:  Ashar Usmani; Roberto F Machado
Journal:  Clin Hemorheol Microcirc       Date:  2018       Impact factor: 2.375
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.